4.6 Article

Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Delphine Planas et al.

Summary: The Omicron variant of SARS-CoV-2, identified in November 2021, has spread rapidly worldwide and shows resistance to most therapeutic monoclonal antibodies and vaccine-elicited antibodies. However, it can be neutralized by antibodies generated by a booster vaccine dose.

NATURE (2022)

Review Cell Biology

Mechanisms of SARS-CoV-2 entry into cells

Cody B. Jackson et al.

Summary: The entry of SARS-CoV-2 into host cells is facilitated by the interaction between the viral spike protein and ACE2, leading to virus-cell membrane fusion, which has been extensively studied at the structural and cellular levels worldwide. This understanding has paved the way for the development of effective vaccines in response to the COVID-19 pandemic, caused by the infection with SARS-CoV-2.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

News Item Multidisciplinary Sciences

COULD NEW COVID VARIANTS UNDERMINE VACCINES? LABS SCRAMBLE TO FIND OUT

Ewen Callaway

NATURE (2021)

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Article Multidisciplinary Sciences

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Tyler N. Starr et al.

Summary: Research has found that mutations in the receptor binding domain (RBD) of SARS-CoV-2 may potentially escape the action of the REGN-COV2 cocktail, providing important information for interpreting mutations observed during viral surveillance.

SCIENCE (2021)

Article Cell & Tissue Engineering

Neutralizing antibodies targeting SARS-CoV-2 spike protein

Shi Xiaojie et al.

Summary: Since it was first identified in Wuhan, China at the end of 2019, SARS-CoV-2 causing the worldwide pandemic has dramatically changed people's lives in multiple aspects. Efforts to curb the progression of the pandemic are urgently ongoing, with promising therapeutic antibodies being developed through various approaches. Studies have shown that neutralizing antibodies against SARS-CoV-2 are mainly targeting the RBD and some non-RBD domains, with convergent germline genes identified for effective antibodies.

STEM CELL RESEARCH (2021)

Article Multidisciplinary Sciences

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape

Zhiqiang Ku et al.

Summary: Antibody cocktails are a promising approach to prevent SARS-CoV-2 escape, with a combination of antibodies CoV2-06 and CoV2-14 identified as effective in preventing viral escape and providing protection in mice, offering new insights for treating COVID-19.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Qianqian Li et al.

Summary: The 501Y.V2 variants of SARS-CoV-2 with multiple mutations are rapidly spreading from South Africa to other countries, showing reduced susceptibility to neutralizing antibodies and potential compromise of monoclonal antibodies and vaccines. Enhanced infectivity in murine ACE2-overexpressing cells suggests the possibility of transmission to mice.
Article Biochemistry & Molecular Biology

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Emma C. Thomson et al.

Summary: SARS-CoV-2 virus can mutate and evade immunity, with mutations like N439K conferring resistance against neutralizing monoclonal antibodies and enhancing binding affinity to hACE2 receptor. Despite similar in vitro replication fitness and clinical outcomes compared to wild type, N439K mutation highlights the importance of ongoing molecular surveillance for guiding vaccine and therapeutic development and usage.
Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

Article Biochemistry & Molecular Biology

Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike

Pei Tong et al.

Summary: Memory B cell reserves can produce protective antibodies against SARS-CoV-2, but the impact on variants is unclear. Studying antibodies from convalescent individuals revealed seven major antibody competition groups, important for neutralizing the virus.
Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers

Edurne Rujas et al.

Summary: By using human apoferritin protomer as a modular subunit, researchers have developed exceptionally potent neutralizers targeting SARS-CoV-2. Combining three different antibody specificities and the fragment crystallizable (Fc) domain on a single multivalent molecule enabled the platform to overcome viral sequence variability and deliver ultrapotent neutralizers against SARS-CoV-2. This MULTi-specific, multi-Affinity antiBODY (Multabody or MB) platform leverages binding avidity and multi-specificity to provide broad neutralization against SARS-CoV-2.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

Allison J. Greaney et al.

Summary: The study found that although the human immune system can produce antibodies that target diverse RBD epitopes, in practice, the polyclonal response to infection tends to be skewed towards a single class of antibodies targeting an epitope that is already undergoing rapid evolution.

NATURE COMMUNICATIONS (2021)

Article Biology

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics

Michael Barton et al.

Summary: The study analyzed the effects of mutations in the Spike protein of SARS-CoV-2 on its interaction with ACE2, finding that most mutations increased affinity with ACE2. Two ACE2 mutations were also found to enhance binding with the Spike protein.

ELIFE (2021)

Article Mathematical & Computational Biology

COVIDium: a COVID-19 resource compendium

Rohit Satyam et al.

Summary: The COVID-19 pandemic has led to a surge in experimental and computational research data, resulting in the development of numerous databases and software tools. To facilitate researchers in navigating and accessing these resources, a compendium named COVIDium has been created, aimed at categorizing and providing quick access to databases and tools for research studies.

DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2021)

Review Biochemical Research Methods

Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2

Md Asif Ahsan et al.

Summary: The COVID-19 pandemic, caused by SARS-CoV-2, poses an unprecedented threat to public health globally. With no approved drugs or vaccines available, urgent research is needed to understand the virus's pathogenesis and develop effective treatments, requiring collaboration and integration of molecular information from researchers worldwide.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Mathematical & Computational Biology

OverCOVID: an integrative web portal for SARS-CoV-2 bioinformatics resources

Md Asif Ahsan et al.

Summary: The ongoing threat of COVID-19 has led to the generation of vast amounts of data regarding the novel coronavirus SARS-CoV-2. To facilitate researchers in accessing these resources and accelerating clinical research, an integrated web portal called OverCOVID has been developed, providing a one-stop platform for accessing publicly available webservers, databases, and tools associated with SARS-CoV-2.

JOURNAL OF INTEGRATIVE BIOINFORMATICS (2021)

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

Article Multidisciplinary Sciences

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Rui Shi et al.

NATURE (2020)

Article Multidisciplinary Sciences

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Bin Ju et al.

NATURE (2020)

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Qianqian Li et al.

Article Chemistry, Physical

Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane

Hyeonuk Woo et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2020)

Correction Microbiology

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike (vol 28, pg 445, 2020)

Jiandong Huo et al.

CELL HOST & MICROBE (2020)

Article Biochemistry & Molecular Biology

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

Daming Zhou et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Article Multidisciplinary Sciences

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

Johanna Hansen et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Structural basis of a shared antibody response to SARS-CoV-2

Meng Yuan et al.

SCIENCE (2020)

Review Multidisciplinary Sciences

SARS-CoV-2 vaccines in development

Florian Krammer

NATURE (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Christopher O. Barnes et al.

NATURE (2020)

Article Multidisciplinary Sciences

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Alejandra Tortorici et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein

Antoni G. Wrobel et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition

Oliver C. Grant et al.

SCIENTIFIC REPORTS (2020)

Review Immunology

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses

Zeinab Abdelrahman et al.

FRONTIERS IN IMMUNOLOGY (2020)

Letter Infectious Diseases

CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants

Intikhab Alam et al.

LANCET INFECTIOUS DISEASES (2020)

Review Infectious Diseases

Mutated COVID-19 may foretell a great risk for mankind in the future

A. A. Dawood

NEW MICROBES AND NEW INFECTIONS (2020)

Article Biochemistry & Molecular Biology

The role of coevolutionary signatures in protein interaction dynamics, complex inference, molecular recognition, and mutational landscapes

Faruck Morcos et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2019)

Review Microbiology

Origin and evolution of pathogenic coronaviruses

Jie Cui et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Review Chemistry, Multidisciplinary

Finding the ΔΔG spot: Are predictors of binding affinity changes upon mutations in protein-protein interactions ready for it?

Cunliang Geng et al.

WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2019)

Editorial Material Infectious Diseases

GISAID: Global initiative on sharing all influenza data - from vision to reality

Yuelong Shu et al.

EUROSURVEILLANCE (2017)

Article Biochemical Research Methods

PRODIGY: a web server for predicting the binding affinity of protein-protein complexes

Li C. Xue et al.

BIOINFORMATICS (2016)

Article Biochemical Research Methods

Evol and ProDy for bridging protein sequence evolution and structural dynamics

Ahmet Bakan et al.

BIOINFORMATICS (2014)

Article Biochemistry & Molecular Biology

MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability

Kazutaka Katoh et al.

MOLECULAR BIOLOGY AND EVOLUTION (2013)

Article Biochemistry & Molecular Biology

BeAtMuSiC: prediction of changes in protein-protein binding affinity on mutations

Yves Dehouck et al.

NUCLEIC ACIDS RESEARCH (2013)